DGAP-News: AlzChem Group AG / Key word(s): Market Report
AlzChem Group AG closes one of the last white spots in the global market for Perlka(R) fertilizer with Canada
Perlka(R) calcium cyanamide can continue its international success story primarily because it is a specialty among fertilizers: Not only does it supply the soil with stable nitrogen and lime, but it also remains in the stable ammonium form in the soil for six to eight weeks longer than many other fertilizers. For this reason, many farmers rely on Perlka(R) to avoid imminent losses in terms of yield and quality in view of shorter crop rotations. With its innovative further development, AlzChem has also succeeded in establishing itself also in new international markets as an important player in the fields of agriculture and health. In Canada, Perlka(R) meets the requirements of the new fertilizer regulations, so that its use there is assured in the long term. The great market potential is reflected, among other things, in the research interest shown by universities. The University of Alberta, for example, is conducting a research project on the application of Perlka(R) in canola. This shows that the positive effects of Perlka(R) on healthy soil and healthy plants can also be seen in an area-rich crop such as canola.
The company sees interesting growth prospects for itself especially in the areas of human and animal nutrition and agriculture. As a result of population growth, it is necessary to achieve efficient food production. Pharmaceutical raw materials and our creatine products can contribute to healthy aging as life expectancy increases. AlzChem is facing up to the goal of sustainability arising from climate change in the field of renewable energies. The fields of fine chemicals and metallurgy offer just as great a perspective.
The broad product range of AlzChem Group AG includes dietary supplements, precursors for corona tests and pharmaceutical raw materials. These developments are our company's response to global trends and developments. AlzChem is ideally positioned in this regard and sees itself as well equipped for an environmentally oriented future and global developments.
The company employs around 1,630 people at four production sites in Germany and one plant in Sweden, as well as two sales companies in the USA and China. In 2020, AlzChem generated consolidated sales of around EUR 379 million and EBITDA of around EUR 53.8 million.
09.07.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
AlzChem Group AG
Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Stuttgart
EQS News ID:
End of News
DGAP News Service